title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Nasdaq Gains 100 Points; CarMax Earnings Top Views - Clene  ( NASDAQ:CLNN ) , Annexon  ( NASDAQ:ANNX ) ",20231221T192303,https://www.benzinga.com/news/earnings/23/12/36350420/nasdaq-gains-100-points-carmax-earnings-top-views,PBLA,0.184834,Bullish,0.352363
Stocks That Hit 52-Week Lows On Monday,20220613T161842,https://www.benzinga.com/markets/options/22/06/27677156/52-weeks-high-and-low-article,PBLA,0.005366,Neutral,-0.004869
"Earnings Scheduled For May 12, 2022",20220512T085523,https://www.benzinga.com/news/earnings/22/05/27156592/earnings-scheduled-for-may-12-2022,PBLA,0.017681,Neutral,-0.045665
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday,20220725T083855,https://www.benzinga.com/news/22/07/28182325/this-technology-stock-surged-235-here-are-77-biggest-movers-from-friday,PBLA,0.057559,Neutral,0.0
"Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday - ABVC BioPharma  ( NASDAQ:ABVC ) , Altimmune  ( NASDAQ:ALT ) ",20220926T074323,https://www.benzinga.com/news/22/09/29002223/why-nanovibronix-shares-surged-over-25-here-are-82-biggest-movers-from-friday,PBLA,0.044551,Somewhat-Bearish,-0.185783
"Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday",20220705T083503,https://www.benzinga.com/news/22/07/27948361/accolade-shares-jump-around-29-heres-75-biggest-movers-from-friday,PBLA,0.061758,Neutral,0.001558
Stocks That Hit 52-Week Lows On Friday,20220603T181147,https://www.benzinga.com/markets/options/22/06/27545977/52-weeks-high-and-low-article,PBLA,0.064018,Neutral,0.046081
Stocks That Hit 52-Week Lows On Thursday,20220602T172744,https://www.benzinga.com/markets/options/22/06/27526024/52-weeks-high-and-low-article,PBLA,0.053402,Neutral,-0.00766
"Pancreatic Endocrine Tumor Market is Expected to Expand at a Healthy Growth Rate by 2032, Assesses DelveInsight | Key Companies - Merck, Theradex, SynerGene, Mirati, Novartis, Syntrix Biosystems, Eli Lilly, Boehringer Ingelheim",20230803T210100,https://www.prnewswire.com/news-releases/pancreatic-endocrine-tumor-market-is-expected-to-expand-at-a-healthy-growth-rate-by-2032-assesses-delveinsight--key-companies---merck-theradex-synergene-mirati-novartis-syntrix-biosystems-eli-lilly-boehringer-ingelheim-301892397.html,PBLA,0.041466,Neutral,-0.038518
